IRadimed Correlations
| 46K Stock | 83.50 3.00 3.47% |
The current 90-days correlation between IRadimed and Mizuno is -0.06 (i.e., Good diversification). The correlation of IRadimed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
IRadimed Correlation With Market
Poor diversification
The correlation between IRadimed and DJI is 0.78 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding IRadimed and DJI in the same portfolio, assuming nothing else is changed.
IRadimed |
The ability to find closely correlated positions to IRadimed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace IRadimed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back IRadimed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling IRadimed to buy it.
Moving together with IRadimed Stock
| 0.75 | PQ9 | BANK MANDIRI | PairCorr |
| 0.7 | PQ9 | BANK MANDIRI | PairCorr |
| 0.77 | PQ9 | BANK MANDIRI | PairCorr |
| 0.8 | D9W | Designer Brands | PairCorr |
| 0.67 | FPP0 | ALTYNGOLD PLC LS | PairCorr |
| 0.75 | K34 | Konecranes Plc | PairCorr |
| 0.7 | 485B | Amcor PLC Split | PairCorr |
| 0.63 | BAS | BASF SE | PairCorr |
| 0.73 | BSI | BE Semiconductor Ind Earnings Call This Week | PairCorr |
| 0.76 | IRV | Integra Resources Corp | PairCorr |
| 0.71 | ASME | ASML Holding NV | PairCorr |
| 0.66 | HKT | HK Electric Investments | PairCorr |
| 0.69 | G40 | GDS Holdings Limited | PairCorr |
| 0.82 | DG1 | DAWSON GEOPHYSICAL | PairCorr |
| 0.75 | 1KT | Keysight Technologies | PairCorr |
| 0.69 | UTDI | UNITED INTERNET N | PairCorr |
| 0.83 | KGHA | KGHM Polska Miedz | PairCorr |
| 0.77 | 1SZ0 | Santacruz Silver Mining Split | PairCorr |
Moving against IRadimed Stock
| 0.6 | BYRA | BANK RAKYAT IND | PairCorr |
| 0.46 | 8LU | TAURUS ENERGY AB | PairCorr |
| 0.43 | SFTU | SoftBank Group Corp Split | PairCorr |
| 0.4 | BZG2 | BANK CENTRAL ASIA | PairCorr |
| 0.34 | BYRA | BANK RAKYAT IND | PairCorr |
| 0.32 | BZG2 | PT Bank Central | PairCorr |
| 0.77 | DBPD | Xtrackers ShortDAX | PairCorr |
| 0.47 | KMY | Kimberly Clark | PairCorr |
Related Correlations Analysis
| -0.65 | 0.44 | 0.75 | 0.88 | 0.49 | 0.88 | MIZ | ||
| -0.65 | -0.22 | -0.81 | -0.68 | -0.85 | -0.66 | SON1 | ||
| 0.44 | -0.22 | 0.2 | 0.48 | 0.15 | 0.5 | 893 | ||
| 0.75 | -0.81 | 0.2 | 0.75 | 0.72 | 0.66 | 92I | ||
| 0.88 | -0.68 | 0.48 | 0.75 | 0.47 | 0.84 | HCMA | ||
| 0.49 | -0.85 | 0.15 | 0.72 | 0.47 | 0.43 | BFP | ||
| 0.88 | -0.66 | 0.5 | 0.66 | 0.84 | 0.43 | YHA | ||
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between IRadimed Stock performing well and IRadimed Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IRadimed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| MIZ | 1.80 | 0.50 | 0.23 | 2.05 | 1.54 | 4.86 | 10.20 | |||
| SON1 | 1.36 | (0.31) | 0.00 | (0.97) | 0.00 | 2.51 | 9.80 | |||
| 893 | 2.01 | 0.02 | (0.01) | 0.14 | 2.40 | 4.02 | 13.77 | |||
| 92I | 0.64 | 0.11 | 0.03 | (0.39) | 0.89 | 1.32 | 8.68 | |||
| HCMA | 1.97 | 0.70 | 0.28 | 6.95 | 1.69 | 6.35 | 11.96 | |||
| BFP | 2.86 | 0.16 | 0.02 | (0.32) | 3.60 | 8.16 | 18.93 | |||
| YHA | 1.39 | 0.19 | 0.05 | (1.08) | 1.88 | 3.23 | 13.58 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in IRadimed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
IRadimed Corporate Management
Elected by the shareholders, the IRadimed's board of directors comprises two types of representatives: IRadimed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IRadimed. The board's role is to monitor IRadimed's management team and ensure that shareholders' interests are well served. IRadimed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IRadimed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Randy Waddell | Vice Marketing | Profile | |
| Jeff Chiprin | Chief Officer | Profile | |
| Lynn Neuhardt | Vice Development | Profile | |
| Chris Williamson | Executive Technology | Profile | |
| Matt Garner | Controller | Profile | |
| John Glenn | Chief Officer | Profile |